Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
JE · Effective Nov 12, 2023
41 active Medicare policies list M31.11, and 1 commercial payer policy lists it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
JE · Effective Nov 12, 2023
JF · Effective Nov 12, 2023
JJ · Effective Apr 30, 2023
JM · Effective Apr 30, 2023
J5 · Effective Sep 16, 2017
J8 · Effective Sep 16, 2017
JE · Effective Oct 8, 2018
JF · Effective Oct 8, 2018
1 policy from 1 payer
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of M31.11 |
|---|---|---|
| ADAMTS13 Assay for Thrombotic Thrombocytopenic Purpura (TTP) | Oct 26, 2023 | Covered |
J9
J9 · Effective May 17, 2026
JH · Effective May 17, 2026
JL · Effective May 17, 2026
J5 · Effective Oct 1, 2015
J8 · Effective Oct 1, 2015
J5 · Effective Oct 1, 2015
J8 · Effective Oct 1, 2015
J15 · Effective Aug 8, 2021
J6 · Effective Nov 1, 2022
JK · Effective Nov 1, 2022
J9 · Effective Oct 1, 2015
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
National · Effective Oct 23, 2025
J6 · Effective Oct 1, 2025
National · Effective Oct 1, 2025
J5 · Effective Oct 1, 2025
J9 · Effective Jan 1, 2026
JL · Effective Jan 1, 2026
J5 · Effective Nov 27, 2025
National · Effective Oct 23, 2025
National · Effective May 17, 2026
National · Effective May 17, 2026
J5 · Effective Feb 26, 2026
J5 · Effective Oct 1, 2025
National · Effective Oct 1, 2025
J6 · Effective Oct 1, 2025
National · Effective Oct 1, 2025